Twenty years on: the impact of fragments on drug discovery

Erlanson, Daniel A., Fesik, Stephen W., Hubbard, Roderick E., Jahnke, Wolfgang, Jhoti, Harren·2016·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2016.109

Cited by (1,000)

Items 101–200 of 1,000

  1. Fragment-based drug discovery and its application to challenging drug targets
    Amanda J. Price, Steven Howard, Benjamin D. Cons · 2017 · Essays in Biochemistry
  2. Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections
    Sarah L. Kidd, Thomas J. Osberger, Natalia Mateu, Hannah F. Sore, David R. Spring · 2018 · Frontiers in Chemistry
  3. DNA-encoded libraries – an efficient small molecule discovery technology for the biomedical sciences
    Verena B. K. Kunig, Marco Potowski, Anne Gohla, Andreas Brunschweiger · 2018 · Biological Chemistry
  4. Multifunctional Building Blocks Compatible with Photoredox-Mediated Alkylation for DNA-Encoded Library Synthesis
    Shorouk O. Badir, Jaehoon Sim, Katelyn Billings, Adam Csakai, Xuange Zhang, Weizhe Dong, Gary Alan Molander · 2020 · Organic Letters
  5. Computer-Aided Drug Design in Epigenetics
    Wenchao Lu, Rukang Zhang, Hao Jiang, Huimin Zhang, Cheng Luo · 2018 · Frontiers in Chemistry
  6. A new ‘golden age’ for the antitubercular target InhA
    Kaja Rožman, Izidor Sosič, Raquel Fernandez, Robert J. Young, Alfonso Mendoza-Losana, Stanislav Gobec, Lourdes Encinas · 2016 · Drug Discovery Today
  7. Virtual Compound Libraries in Computer-Assisted Drug Discovery
    Niek van Hilten, Florent Chevillard, Peter Kolb · 2019 · Journal of Chemical Information and Modeling
  8. Fragment Hits: What do They Look Like and How do They Bind?
    Fabrizio Giordanetto, Chentian Jin, Lindsay Willmore, Miklós Fehér, David Elliot Shaw · 2019 · Journal of Medicinal Chemistry
  9. DNA Encoded Libraries: A Visitor's Guide
    Dillon T. Flood, Cian Kingston, Julien C. Vantourout, Philip E. Dawson, Phil S. Baran · 2020 · Israel Journal of Chemistry
  10. Rapid Assembly of Saturated Nitrogen Heterocycles in One‐Pot: Diazo‐Heterocycle “Stitching” by N–H Insertion and Cyclization
    Alexander J. Boddy, Dominic P. Affron, Christopher J. Cordier, Emma L. Rivers, Alan C. Spivey, James A. Bull · 2018 · Angewandte Chemie International Edition
  11. Re-engineering natural products to engage new biological targets
    Stephen E. Motika, Paul J. Hergenrother · 2020 · Natural Product Reports
  12. Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
    Adam J. Wolpaw, Richard W. Bayliss, Gabriele Büchel, Chi Van Dang, Martin Eilers, William Clay Gustafson, Gwenn M. Hansen, Natalia Jura, Stefan Knapp, Mark A. Lemmon et al. · 2021 · Cancer Research
  13. Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
    A. Douangamath, A.J. Powell, D. Fearon, P.M. Collins, Romain Talon, Tobias J. Krojer, R. Skyner, J. Brandão-Neto, Louise E. Dunnett, Alexandre M.M. Dias et al. · 2021 · Journal of Visualized Experiments
  14. A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery
    Shaogeng Tang, Peter S. Kim · 2019 · Proceedings of the National Academy of Sciences
  15. Photochemical Methods Applied to DNA Encoded Library (DEL) Synthesis
    Bianca T. Matsuo, Albert Granados, Guillaume Levitre, Gary Alan Molander · 2023 · Accounts of Chemical Research
  16. A bright future for fragment-based drug discovery: what does it hold?
    Célien Jacquemard, Esther Kellenberger · 2019 · Expert Opinion on Drug Discovery
  17. Recent Advances in the Synthesis and Reactivity of Isothiazoles
    Ana De Oliveira Silva, James McQuade, Michal Szostak · 2019 · Advanced Synthesis & Catalysis
  18. Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
    Jakob S. Pallesen, Dilip Narayanan, Kim T. Tran, Sara M. Ø. Solbak, Giuseppe Marseglia, Louis M. E. Sørensen, Lars Jakobsen Høj, Federico Munafò, Rosa María Carmona, Anthony D. Garcia et al. · 2021 · Journal of Medicinal Chemistry
  19. Photoredox-mediated hydroalkylation and hydroarylation of functionalized olefins for DNA-encoded library synthesis
    Shorouk O. Badir, Alexander Lipp, Matthias Krumb, María Jesús Cabrera‐Afonso, Lisa Marie Kammer, Victoria E. Wu, Minxue Huang, Adam Csakai, Lisa A. Marcaurelle, Gary Alan Molander · 2021 · Chemical Science
  20. Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry
    Hoan Vu, Liliana Pedro, Tin Mak, B. P. McCormick, Jessica Rowley, Miaomiao Liu, Angela Di Capua, Billy J. Williams‐Noonan, Ngoc Bich Pham, Rebecca H. Pouwer et al. · 2018 · ACS Infectious Diseases
  21. Fragment-to-Lead Medicinal Chemistry Publications in 2015
    Christopher N. Johnson, Daniel A. Erlanson, Christopher W. Murray, David C. Rees · 2016 · Journal of Medicinal Chemistry
  22. Using Physicochemical Measurements to Influence Better Compound Design
    Shenaz B. Bunally, Christopher N. Luscombe, Robert J. Young · 2019 · SLAS DISCOVERY
  23. The 3F Library: Fluorinated Fsp3‐Rich Fragments for Expeditious 19F NMR Based Screening
    Nikolaj S. Troelsen, Elena Shanina, Diego González‐Romero, Daniela Danková, Ida S. A. Jensen, Katarzyna Śniady‐Maciążek, Faranak Nami, Hengxi Zhang, Christoph Rademacher, Ana Cuenda et al. · 2019 · Angewandte Chemie International Edition
  24. Cells, drugs and NMR
    Gregg Siegal, Philipp Selenko · 2019 · Journal of Magnetic Resonance
  25. NMR studies of ligand binding
    Christoph Nitsche, Gottfried Otting · 2017 · Current Opinion in Structural Biology
  26. Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding site
    Pierre G. Matricon, Anirudh Ranganathan, Eugene Warnick, Zhan‐Guo Gao, Axel Rudling, Catia Lambertucci, Gabriella Marucci, Aitakin Ezzati, Mariama Jaiteh, Diego Dal Ben et al. · 2017 · Scientific Reports
  27. Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
    Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, Ge‐Fei Hao, Guang‐Fu Yang · 2023 · Trends in Biochemical Sciences
  28. Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2
    Tom D. Heightman, Valério Berdini, Hannah E. Braithwaite, Ildiko M. Buck, Megan A. Cassidy, Juan Castro, Aurélie Courtin, James E. H. Day, Charlotte East, Lynsey Fazal et al. · 2018 · Journal of Medicinal Chemistry
  29. Paramagnetic NMR in drug discovery
    Charlotte A. Softley, Mark J. Bostock, Grzegorz M. Popowicz, Michael Sattler · 2020 · Journal of Biomolecular NMR
  30. FragMAX: the fragment-screening platform at the MAX IV Laboratory
    G.M.A. Lima, V. Talibov, Elmir Jagudin, Céleste Sèle, Maria Nyblom, Wolfgang Knecht, Derek T. Logan, Tove Sjögren, U. Müeller · 2020 · Acta Crystallographica Section D Structural Biology
  31. Discovery of De Novo Macrocyclic Peptides by Messenger RNA Display
    Hayden Peacock, Hiroaki Suga · 2021 · Trends in Pharmacological Sciences
  32. The Ligand Binding Landscape of Diacylglycerol Kinases
    Caroline E. Franks, Sean Campbell, Benjamin W. Purow, Thurl E. Harris, Ku‐Lung Hsu · 2017 · Cell chemical biology
  33. 14-3-3 adaptor protein-protein interactions as therapeutic targets for CNS diseases
    Andrew Kaplan, Christian Ottmann, Alyson E. Fournier · 2017 · Pharmacological Research
  34. Unveiling the druggable RNA targets and small molecule therapeutics
    Joanna Sztuba-Solińska, Gabriela Chávez‐Calvillo, Sabrina Elizabeth Cline · 2019 · Bioorganic & Medicinal Chemistry
  35. Design and Synthesis of 56 Shape‐Diverse 3D Fragments
    Thomas D. Downes, Simon P. Jones, Hanna F. Klein, Mary C. Wheldon, Masakazu Atobe, Paul S. Bond, James D. Firth, Ngai S. Chan, Laura Waddelove, Roderick E. Hubbard et al. · 2020 · Chemistry - A European Journal
  36. Heterocyclic Iodoniums for the Assembly of Oxygen-Bridged Polycyclic Heteroarenes with Water as the Oxygen Source
    Daqian Zhu, Zhouming Wu, Bingling Luo, Yongliang Du, Panpan Liu, Yunyun Chen, Yumin Hu, Peng Huang, Shijun Wen · 2018 · Organic Letters
  37. In silico screening of modulators of magnesium dissolution
    Christian Feiler, Di Mei, Bahram Vaghefinazari, Tim Würger, Robert H. Meißner, Bérengère Luthringer-Feyerabend, David Alan Winkler, Mikhail L. Zheludkevich, Sviatlana V. Lamaka · 2019 · Corrosion Science
  38. Affinity measurement of strong ligands with NMR spectroscopy: Limitations and ways to overcome them
    Claudio Dalvit, Isabel Gmür, Philip Rößler, Alvar D. Gossert · 2023 · Progress in Nuclear Magnetic Resonance Spectroscopy
  39. Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors
    Melissa L. Boby, D. Fearon, Matteo Paolo Ferla, Mihajlo Filep, L. Koekemoer, Matthew C. Robinson, John D. Chodera, Alpha A. Lee, Nir London, Annette von Delft et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Enabling STD-NMR fragment screening using stabilized native GPCR: A case study of adenosine receptor
    Sébastien Igonet, Claire Raingeval, Erika Cecon, Maja Pučić‐Baković, Gordan Lauc, Olivier Cala, Maciej Baranowski, Javier Pérez, Ralf Jockers, Isabelle Krimm et al. · 2018 · Scientific Reports
  41. Insights into the development of chemical probes for RNA
    Brittany S. Morgan, Jordan E. Forte, Amanda E. Hargrove · 2018 · Nucleic Acids Research
  42. A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes
    Seth M. Cohen · 2017 · Accounts of Chemical Research
  43. A Perspective on the Analytical Challenges Encountered in High-Throughput Experimentation
    Rachel Grainger, Stuart Whibley · 2021 · Organic Process Research & Development
  44. 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery
    Claire Raingeval, Olivier Cala, Béatrice Brion, Marc Le Borgne, Roderick E. Hubbard, Isabelle Krimm · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
  45. Discovery of a B-Cell Lymphoma 6 Protein–Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach
    Yusuke Kamada, Nozomu Sakai, Satoshi Sogabe, Koh Ida, Hideyuki Oki, Kotaro Sakamoto, Weston Lane, G. Snell, Motoo Iida, Yasuhiro Imaeda et al. · 2017 · Journal of Medicinal Chemistry
  46. A Modular Approach to Dibenzo‐fused ϵ‐Lactams: Palladium‐Catalyzed Bridging‐C−H Activation
    Yinghua Yu, Liyao Ma, Jiajin Xia, Luoting Xin, Lei Zhu, Xueliang Huang · 2020 · Angewandte Chemie International Edition
  47. Protein‐protein interactions as antibiotic targets: A medicinal chemistry perspective
    Cossar, Peter J., Lewis, Peter J., McCluskey, Adam · 2020 · Medicinal Research Reviews
  48. Reversible Covalent Imine-Tethering for Selective Stabilization of 14-3-3 Hub Protein Interactions
    Peter J. Cossar, M. Wolter, L.v. Dijck, Dario Valenti, Laura M. Levy, Christian Ottmann, Luc Brunsveld · 2021 · Journal of the American Chemical Society
  49. Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
    Dilip Narayanan, Kim T. Tran, Jakob S. Pallesen, Sara M. Ø. Solbak, Yuting Qin, Elina Mukminova, Martina Luchini, Kristina O. Vasilyeva, Dorleta González Chichón, Georgia Goutsiou et al. · 2022 · Journal of Medicinal Chemistry
  50. Deep Lead Optimization: Leveraging Generative AI for Structural Modification
    Odin Zhang, Haitao Lin, Hui Zhang, Huifeng Zhao, Yufei Huang, Chang‐Yu Hsieh, Peichen Pan, Tingjun Hou · 2024 · Journal of the American Chemical Society
  51. Fragments: where are we now?
    James Osborne, Stanislava Panova, Magdalini Rapti, Tatsuya Urushima, Harren Jhoti · 2020 · Biochemical Society Transactions
  52. Real-Time Insights into Biological Events: In-Cell Processes and Protein-Ligand Interactions
    Linda Cerofolini, Stefano Giuntini, Letizia Barbieri, Matteo Pennestri, Anna Codina, Marco Fragai, Lucia Banci, Enrico Luchinat, Enrico Ravera · 2018 · Biophysical Journal
  53. Stereoselective Palladium-Catalyzed 1,3-Arylboration of Unconjugated Dienes for Expedient Synthesis of 1,3-Disubstituted Cyclohexanes
    Hai‐Liang Pang, Dong Wu, Hengjiang Cong, Guoyin Yin · 2019 · ACS Catalysis
  54. F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening
    J. Wollenhaupt, A. Metz, Tatjana Barthel, G.M.A. Lima, A. Heine, U. Müeller, Gerhard Klebe, Manfred S. Weiss · 2020 · Structure
  55. NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment
    François‐Xavier Cantrelle, Emmanuelle Boll, Lucile Brier, Danai Moschidi, Sandrine Belouzard, Valérie Landry, Florence Leroux, Frédérique Dewitte, Isabelle Landrieu, Jean Dubuisson et al. · 2021 · Angewandte Chemie International Edition
  56. General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept
    Dinler A. Antunes, Didier Devaurs, Mark Moll, Gregory A. Lizee, Lydia E. Kavraki · 2018 · Scientific Reports
  57. Applications of In-Cell NMR in Structural Biology and Drug Discovery
    CongBao Kang · 2019 · International Journal of Molecular Sciences
  58. Flow Chemistry: Towards A More Sustainable Heterocyclic Synthesis
    Pedro Brandão, Marta Piñeiro, Teresa M. V. D. Pinho e Melo · 2019 · European Journal of Organic Chemistry
  59. Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19 F NMR‐Based Screening
    Andreas Lingel, Anna Vulpetti, Tony Reinsperger, Andrew Proudfoot, Régis Denay, Alexandra Frommlet, Christelle Henry, Ulrich Hommel, Alvar D. Gossert, Burkhard Luy et al. · 2020 · Angewandte Chemie International Edition
  60. Bcl-2 on the brink of breakthroughs in cancer treatment
    John C. Reed · 2017 · Cell Death and Differentiation
  61. NMR-Fragment Based Virtual Screening: A Brief Overview
    Meenakshi Singh, Benjamin Tam, Barak Akabayov · 2018 · Molecules
  62. Chemistry‐driven Hit‐to‐lead Optimization Guided by Structure‐based Approaches
    Laurent Hoffer, Christophe Müller, Philippe Roche, Xavier Morelli · 2018 · Molecular Informatics
  63. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis
    Swadesh Kumar Das, Santanu Maji, Stephen L. Wechman, Praveen Bhoopathi, Anjan K. Pradhan, Sarmistha Talukdar, Devanand Sarkar, Joseph W. Landry, Chunqing Guo, Xiang‐Yang Wang et al. · 2020 · Pharmacological Research
  64. Arranging Small Molecules with Subnanometer Precision on DNA Origami Substrates for the Single‐Molecule Investigation of Protein–Ligand Interactions
    Jingyuan Huang, Antonio Suma, Meiying Cui, Guido Grundmeier, Vincenzo Carnevale, Yixin Zhang, Charlotte Kielar, Adrian Keller · 2020 · Small Structures
  65. A Single‐Stranded DNA‐Encoded Chemical Library Based on a Stereoisomeric Scaffold Enables Ligand Discovery by Modular Assembly of Building Blocks
    Gabriele Bassi, Nicholas Favalli, Miriam Vuk, Marco Catalano, Adriano Luca Martinelli, Anika Trenner, Antônio Porro, Su Yang, Chuin Lean Tham, Mustafa Moroglu et al. · 2020 · Advanced Science
  66. Mining Natural Products for Macrocycles to Drug Difficult Targets
    Fabio Begnini, Vasanthanathan Poongavanam, Björn Over, Marie Castaldo, Stefan Geschwindner, Patrik Johansson, Mohit Tyagi, Christian Tyrchan, Lisa Wissler, Peter Sjö et al. · 2020 · Journal of Medicinal Chemistry
  67. Selection of DNA‐Encoded Dynamic Chemical Libraries for Direct Inhibitor Discovery
    Yuqing Deng, Jianzhao Peng, Feng Xiong, Yinan Song, Yu Zhou, Jianfu Zhang, Fong Sang Lam, Chao Xie, Wenyin Shen, Yiran Huang et al. · 2020 · Angewandte Chemie International Edition
  68. Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
    Kirsten McAulay, Alan E Bilsland, Marta Bon · 2022 · Pharmaceuticals
  69. Target Engagement Assays in Early Drug Discovery
    Sahra St John‐Campbell, Gurdip Bhalay · 2025 · Journal of Medicinal Chemistry
  70. When fragments link: a bibliometric perspective on the development of fragment-based drug discovery
    Angelo Kenneth S. Romasanta, Peter van der Sijde, Iina Hellsten, Roderick E. Hubbard, György Miklós Keserű, Jacqueline E. van Muijlwijk‐Koezen, Iwan J. P. de Esch · 2018 · Drug Discovery Today
  71. An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases
    László Petri, Attila Egyed, Dávid Bajusz, Tı́mea Imre, Anasztázia Hetényi, Tamás A. Martinek, Péter Ábrányi‐Balogh, György Miklós Keserű · 2020 · European Journal of Medicinal Chemistry
  72. Two Methods, One Goal: Structural Differences between Cocrystallization and Crystal Soaking to Discover Ligand Binding Poses
    B. Wienen-Schmidt, Matthias Oebbeke, Khang Ngo, A. Heine, Gerhard Klebe · 2020 · ChemMedChem
  73. An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
    Angel Gonzalez-Valero, Audrey G. Reeves, Annika C. S. Page, Patrick J. Moon, Edward Miller, Katia Coulonval, Steven W. M. Crossley, Xiao Xie, Dan He, Patricia Zhang Musacchio et al. · 2022 · Journal of the American Chemical Society
  74. Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design
    Yang Yu, Junhong Huang, Hu He, Jing Han, Geyan Ye, Tingyang Xu, Xianqiang Sun, Xiumei Chen, Xiaoming Ren, Chunlai Li et al. · 2023 · ACS Medicinal Chemistry Letters
  75. The current role and evolution of X-ray crystallography in drug discovery and development
    Vanessa Bijak, Michal Szczygiel, Joanna Lenkiewicz, Michał Gucwa, David R. Cooper, Krzysztof Murzyn, Wladek Minor · 2023 · Expert Opinion on Drug Discovery
  76. Solution NMR Spectroscopy in Target-Based Drug Discovery
    Yan Li, CongBao Kang · 2017 · Molecules
  77. Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands
    Florent Chevillard, Helena Rimmer, Cecilia Betti, Els Pardon, Steven Ballet, Niek van Hilten, Jan Steyaert, Wibke E. Diederich, Peter Kolb · 2018 · Journal of Medicinal Chemistry
  78. Solvents to Fragments to Drugs: MD Applications in Drug Design
    Lucas A. Defelipe, Juan Pablo Arcon, Carlos Pablo Modenutti, Marcelo Adrian Marti, Adrian Gustavo Turjanski, Xavier Barril · 2018 · Molecules
  79. A Dual-Specific Targeting Approach Based on the Simultaneous Recognition of Duplex and Quadruplex Motifs
    Thi Quynh Ngoc Nguyen, Kah Wai Lim, Anh Tuân Phan · 2017 · Scientific Reports
  80. Increase of enzyme activity through specific covalent modification with fragments
    John F. Darby, Masakazu Atobe, James D. Firth, Paul S. Bond, G.J. Davies, Peter O’Brien, Roderick E. Hubbard · 2017 · Chemical Science
  81. Computational Fragment-Based Design Facilitates Discovery of Potent and Selective Monoamine Oxidase-B (MAO-B) Inhibitor
    Chuanfei Jin, Zhi-Zheng Wang, Kang-Zhi Chen, Tengfei Xu, Ge‐Fei Hao · 2020 · Journal of Medicinal Chemistry
  82. Targeting protein-protein interaction interfaces in COVID-19 drug discovery
    Chung‐ke Chang, Shanmeng Lin, Roshan Satange, Shih‐Chao Lin, Sin-Cih Sun, Hung‐Yi Wu, Kylene Kehn‐Hall, Ming‐Hon Hou · 2021 · Computational and Structural Biotechnology Journal
  83. ERK2 mini-fragment binding
    Marc O’Reilly, Anne Cleasby, Thomas G. Davies, Richard J. Hall, R. Frederick Ludlow, Christopher W. Murray, Dominic Tisi, Harren Jhoti · 2018 · Worldwide Protein Data Bank
  84. Fragment Libraries Designed to Be Functionally Diverse Recover Protein Binding Information More Efficiently Than Standard Structurally Diverse Libraries
    Anna Carbery, R. Skyner, F. von Delft, Charlotte Mary Deane · 2022 · Journal of Medicinal Chemistry
  85. Affinity selection mass spectrometry speeding drug discovery
    Renaud Prudent, Hugues Lemoine, Jarrod J. Walsh, Didier Roche · 2023 · Drug Discovery Today
  86. Molecular fragmentation as a crucial step in the AI-based drug development pathway
    Shao Jinsong, Qifeng Jia, Xing Chen, Yajie Hao, Li Wang · 2024 · Communications Chemistry
  87. t-SMILES: a fragment-based molecular representation framework for de novo ligand design
    Juan-Ni Wu, Tong Wang, Yue Chen, Li‐Juan Tang, Hai‐Long Wu, Ru‐Qin Yu · 2024 · Nature Communications
  88. Modeling protein–ligand interactions for drug discovery in the era of deep learning
    Y.X. Wang, Yibo Li, Jiaxiao Chen, Luhua Lai · 2025 · Chemical Society Reviews
  89. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4
    Yan Li, Shuang Liu, Elizabeth Yihui Ng, Rong Li, Anders Poulsen, Jeffrey Hill, Ajaybabu V. Pobbati, Alvin W. Hung, Wanjin Hong, Thomas H. Keller et al. · 2018 · Biochemical Journal
  90. Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design
    Huimin Cheng, Brian M. Linhares, Wenbo Yu, Mariano Cárdenas, Yong Ai, Wenjuan Jiang, Alyssa Winkler, Sandra Cohen, Ari M. Melnick, Alexander D. MacKerell et al. · 2018 · Journal of Medicinal Chemistry
  91. Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
    Daniela Loessner, Peter Goettig, Sarah Preis, Johanna Felber, Holger Bronger, Judith Ann Clements, Julia Dorn, Viktor Magdolen · 2018 · Expert Opinion on Therapeutic Targets
  92. Cycloaddition Strategies for the Synthesis of Diverse Heterocyclic Spirocycles for Fragment‐Based Drug Discovery
    Thomas A. King, Hannah L. Stewart, Kim T. Mortensen, Andrew J. P. North, Hannah F. Sore, David R. Spring · 2019 · European Journal of Organic Chemistry
  93. Target-Directed Approaches for Screening Small Molecules against RNA Targets
    Hafeez S. Haniff, Laurent Knerr, Jonathan L. Chen, Matthew David Disney, Helen Louise Lightfoot · 2020 · SLAS DISCOVERY
  94. Scopy: an integrated negative design python library for desirable HTS/VS database design
    Ziyi Yang, Zhijiang Yang, Aiping Lü, Tingjun Hou, Dongsheng Cao · 2020 · Briefings in Bioinformatics
  95. Impact of structural biologists and the Protein Data Bank on small-molecule drug discovery and development
    Stephen Kevin Burley · 2021 · Journal of Biological Chemistry
  96. Fragment-based drug design facilitates selective kinase inhibitor discovery
    Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, Ge‐Fei Hao, Guang‐Fu Yang · 2021 · Trends in Pharmacological Sciences
  97. Fragment-Based Design of a Potent MAT2a Inhibitor and in Vivo Evaluation in an MTAP Null Xenograft Model
    Claudia De Fusco, Marianne Schimpl, Ulf Börjesson, Tony Cheung, Iain T. Collie, Laura Evans, Priyanka Narasimhan, Christopher J. Stubbs, Mercedes Vázquez–Chantada, David J. Wagner et al. · 2021 · Journal of Medicinal Chemistry
  98. Fragment‐Based Drug Discovery for RNA Targets
    Kasper P. Lundquist, Vipul Navinchandra Panchal, Charlotte Held Gotfredsen, Ruth Brenk, Mads H. Clausen · 2021 · ChemMedChem
  99. Novel series of triazole containing coumarin and isatin based hybrid molecules as acetylcholinesterase inhibitors
    Kavita Bhagat, Jatinder Vir Singh, Aakriti Sharma, Arshmeet Kaur, Nitish Kumar, Harmandeep Kaur Gulati, Atamjit Singh, Harbinder Singh, Preet Mohinder Singh Bedi · 2021 · Journal of Molecular Structure
  100. Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
    Luca G. Mureddu, Geerten W. Vuister · 2022 · Frontiers in Molecular Biosciences